Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Development and Manufacture of Pharmaceutical Products for Addiction Treatment

Active
N01DA118899PresolicitationFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institute on Drug Abuse (NIDA) is seeking proposals exclusively from qualified small businesses under NAICS Code 541712 for a contract focused on the development and manufacture of stable pharmaceutical dosage forms intended for treating drug addiction. This opportunity entails providing comprehensive services including preformulation studies, dosage form development and manufacturing, analytical method validation, stability studies, packaging, and delivery of pharmaceutical products for use in preclinical and clinical research. Storage facilities must be adequate to handle bulk drug substances, including controlled substances, and the contractor must hold appropriate DEA registrations for Schedules II through V, with the capability or commitment to obtain registrations for Schedule I substances if required. All activities must adhere to FDA current Good Manufacturing Practice (cGMP) and/or Good Laboratory Practices (GLP), with data prepared in formats suitable for FDA Drug Master Files, Investigational New Drug (IND) applications, or New Drug Applications (NDA). The contract is structured as a cost reimbursement completion contract with a base period of one year and four annual options, including possible option tasks and quantities. The solicitation (RFP No. N01DA-11-8899) will be available electronically from March 3, 2011, with proposals due around May 3, 2011. Submission guidelines and detailed requirements are contained in the RFP package accessible via FedBizOpps or the NIDA website. While the contract is exclusively set aside for small businesses, the government encourages those capable of meeting the requirements with commercial items to express interest within 15 days of the notice. The contract opportunity does not use acquisition policies applicable to commercial items under FAR Part 12 and does not guarantee award. Contact information for the contract specialist and contracting officer is provided for further inquiries.

General Info

NIDA seeks small businesses for pharmaceutical development, manufacturing, DEA registration, and FDA-compliant research contract.

Agency

N/A

NAICS

541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Place of Performance

Not specified

Set-Aside

SBA

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhasePresolicitation
Posted

Presolicitation

Notice updated

The notice description changed.

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Nicole BennettContract Specialist
Brian H O'LaughlinContracting Officer

Full Description

Show more
This Procurement is a 100% Small Business Set-Aside. The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified Small Businesses (NAICS Code 541712) concerning the following: Having in-house capability to develop medications for the treatment of drug addiction. This contract is to provide the Government a resource for the development and manufacture of stable dosage forms for use in preclinical and clinical studies. Qualifications include: 1) Have the ability to conduct preformulation studies on drug substances, developing and manufacturing dosage forms, developing and validating analytical methods for dosage forms, carrying out stability studies, packaging and delivery of the pharmaceutical products to NIDA designated sites. 2) Provide adequate facilities for the storage of bulk drug substances, including controlled substances, and their finished dosage forms. 3) Contractor shall have appropriate DEA Registrations for Schedules II-V Controlled Substances in order to use the controlled substances in research and manufacture of dosage forms under the Controlled Substance Act of 1970. 4) Contractor must either possess or demonstrate the ability to obtain DEA Registrations for Schedule I Controlled Substances should the research and manufacture of the Schedule I drugs be required. 5) Contractor shall carry out the tasks in compliance with the Food and Drug Administration's (FDA's) current Good Manufacturing Practice regulations (cGMP) and/or Good Laboratory Practices (GLP). 6) The data and documentation prepared should be in a format acceptable to the Food and Drug Administration (FDA) for inclusion in Drug Master Files (DMF), Investigational New Drugs (IND) or New Drug Applications (NDA). We anticipate the award of one cost reimbursement completion contract for a base period of one year plus four one year options. RFP No. N01DA-11-8899 will be available electronically on or about March 3, 2011. You will access the RFP through the FedBizOpps (URL: http://www.fbo.gov) or through the NIDA website: (URL: http://www.nida.nih.gov/RFP/RFPList.html). All information required for the submission of a proposal is contained in or accessible through the RFP package. Responses are due to be received in the Contracting Office on or about May 3, 2011. NIDA will consider proposals submitted by any responsible offeror. This advertisement does not commit the Government to award a contract. Based upon market research, the Government is not using the policies contained in Part 12, Acquisition of Commercial Items, in its solicitation for the described supplies or services. However, interested persons may identify to the contracting officer their interest and capability to satisfy the Government's requirement with a commercial item within 15 days of this notice.

Similar Contracts

Same NAICS industry code

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS